EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice

Jozefina Casuscelli, Yann-Alexandre Vano, Wolf Herve Fridman, James J Hsieh

Kidney Cancer · 2017

DOI: 10.3233/kca-170008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Kidney Cancer, 2017. Verfasst von Jozefina Casuscelli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Ludwig-Maximilians University, Munich, Germany. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma (RCC) encompasses a wide spectrum of morphologically and molecularly distinct (>10) cancer subtypes originated from the kidney epithelium. Metastatic RCC (mRCC) is lethal and refractory to conventional chemotherapeutic agents. The incorporation of targeted therapies and immune checkpoint inhibitors into the current practice of mRCC has markedly improved the median overall survival of clear cell RCC (ccRCC) patients, the most common subtype, but not rare kidney cancer (RKC or non-ccRCC, nccRCC). Varied treatment response in mRCC patients is observed, which presents clinical challenges/opportunities at the modern mRCC therapeutic landscape consisting of 12 approved drugs representing 6 different effective mechanisms. Key contributing factors include inter- and intra-RCC heterogeneity. With the advances in pan-omics technologies, we now have a better understanding of the molecular pathobiology of individual RCC subtype. Here, we attempt to classify ccRCC based on contemporary molecular features with emphasis on their respective potential significance in clinical practice.

Schlagwörter

Stichwörter der Autor:innen

Kidney cancerbiomarkersgenomicsmetabolomicsmolecular classificationprecision medicineproteomicstherapeuticstranscriptomics

Autor:innen und Institutionen

  • Department of Urology, Ludwig-Maximilians University, Munich, Germany.
  • Oncologie Médicale, Hôpital Européen Georges Pompidou and Centre de Recherche des Cordeliers, Paris, France.
  • INSERM, UMR_S 1138, Cordeliers Research Center, Team Cancer, Immune Control and Escape, Paris 5 Descartes University, Paris, France.
  • Molecular Oncology, Department of Medicine, Siteman Cancer Center, Washington University, St. Louis, MO, USA.

Zitieren

APA

Casuscelli, J., Vano, Y. A., Fridman, W. H., & Hsieh, J. J. (2017). Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice. Kidney Cancer. https://doi.org/10.3233/kca-170008

Vancouver

Casuscelli J, Vano YA, Fridman WH, Hsieh JJ. Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice. Kidney Cancer. 2017. doi:10.3233/kca-170008

BibTeX
@article{Casuscelli2017,
  author = {Casuscelli, Jozefina and Vano, Yann-Alexandre and Fridman, Wolf Herve and Hsieh, James J},
  title = {Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice},
  journal = {Kidney Cancer},
  year = {2017},
  doi = {10.3233/kca-170008}
}
Kostenlos starten →